Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Current Leases (2016 - 2018)

Historic Current Leases for Gsk (GLAXF) over the last 3 years, with Q4 2018 value amounting to $30.9 million.

  • Gsk's Current Leases rose 113.35% to $30.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $30.9 million, marking a year-over-year increase of 113.35%. This contributed to the annual value of $32.1 million for FY2018, which is 818.11% up from last year.
  • As of Q4 2018, Gsk's Current Leases stood at $30.9 million, which was up 113.35% from $30.5 million recorded in Q4 2017.
  • Gsk's Current Leases' 5-year high stood at $30.9 million during Q4 2018, with a 5-year trough of $28.6 million in Q4 2016.
  • Its 3-year average for Current Leases is $30.0 million, with a median of $30.5 million in 2017.
  • Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 679.23% in 2017, then surged by 113.35% in 2018.
  • Over the past 3 years, Gsk's Current Leases (Quarter) stood at $28.6 million in 2016, then increased by 6.79% to $30.5 million in 2017, then grew by 1.13% to $30.9 million in 2018.
  • Its Current Leases stands at $30.9 million for Q4 2018, versus $30.5 million for Q4 2017 and $28.6 million for Q4 2016.